https://www.nuaxia.com/fr/post/meiji-seika-pharma-and-serum-institute-partner-to-bring-japanese-encephalitis-vaccine-to-india-4
Meiji Seika Pharma and Serum Institute partner to bring Japanese encephalitis vaccine to India
Aug 25, 2026 - Meiji Seika Pharma group company KM Biologics and Serum Institute of India (SII) are collaborating to transfer technology for the development and manufacture...
meiji seika pharmajapanese encephalitis vaccineseruminstitutepartner
https://corp.arcalis.co.jp/en/news/meiji-seika-pharma-submitted-new-drug-application-to-manufacture-and-market-arct-154-in-japan/
Meiji Seika Pharma Submitted New Drug Application to Manufacture and Market ARCT-154 in...
ARCALIS was founded in 2021 as a joint venture between Axcelead, Inc. and Arcturus Therapeutics. The company provides drug discovery support, CMC development,...
meiji seika pharmanew drug applicationsubmittedmanufacturemarket